½ÃÀåÁ¶»çº¸°í¼
ÀÇ·á±â±â
ÀǾàǰ
Àç·á/ÈÇÐ
Åë½Å/IT
»ê¾÷¿ë±â°è
¿¡³ÊÁö/ȯ°æ
ÀüÀÚºÎǰ/¹ÝµµÃ¼
ÀÚµ¿Â÷
Ç×°ø¿ìÁÖ/¹æÀ§
½Äǰ/À½·á
ÀϹݼҺñÀç
ÀÎÇÁ¶ó
±ÝÀ¶/¹ðÅ·
¿¬°£Á¤º¸¼ºñ½º
¸ÂÃãÇü½ÃÀåÁ¶»ç
±Û·Î¹úÆÄÆ®³Ê
¸ÞÀϸµ¼ºñ½º
ÀÌ¿ë¾È³»
ȸ»ç¼Ò°³
»ùÇà ¿äû ¸ñ·Ï
īƮ
¹®ÀÇ
|
|
|
Ȩ
>
Áö¿ª
>
ºÏ¹Ì
> ÀǾàǰ
¼¼°è ½ÃÀå
¾Æ½Ã¾ÆÅÂÆò¾ç
ºÏ¹Ì
À¯·´
¶óƾ¾Æ¸Þ¸®Ä«
¾ÆÇÁ¸®Ä«
秵ºÏ¹Ì Áö¿ªÀÇ ½ÃÀå Á¶»ç º¸°í¼ - ÀǾàǰ
Àüü Ä«Å×°í¸®
(1871)
ÀÚµ¿Â÷
( 155 )
Åë½Å/IT
( 249 )
ÀüÀÚºÎǰ/¹ÝµµÃ¼
( 98 )
¿¡³ÊÁö/ȯ°æ
( 119 )
ÀǾàǰ
( 174 )
ÀÇ·á±â±â
( 455 )
Ç×°ø¿ìÁÖ/¹æÀ§
( 64 )
Àç·á/ÈÇÐ
( 340 )
½Äǰ/À½·á
( 17 )
»ê¾÷¿ë±â°è
( 147 )
ÀϹݼҺñÀç
( 15 )
ÀÎÇÁ¶ó
( 32 )
±ÝÀ¶/¹ðÅ·
( 6 )
°Ë»ö
Á¦¸ñ °Ë»ö
1
-
25
¸®ºä (Àüü£º
174
°Ç)
Á¤·Ä
¹ßÇàÀÏ
ÇѱÛÁ¦¸ñ
¿µ¹®Á¦¸ñ
¸®¼Ä¡»ç
°¡°Ý
Ç¥½Ã °Ç¼ö
25
50
100
1
2
3
4
5
6
7
´ÙÀ½
Medical AffairsÀÇ ÆòÆÇ(¹Ì±¹) : °Ç¼±¼º °üÀý¿°
Medical Affairs Reputations (US) - Psoriatic Arthritis
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1773145
¹ßÇàÀÏ
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
NPS+(¹Ì±¹) : ½Å¼¼Æ÷¾Ï(RCC)
NPS+ (US) - Renal Cell Carcinoma
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1773138
¹ßÇàÀÏ
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯¿¡ ´ëÇÑ °øÁßÀ§»ý ÁöÃâ : µ¥ÀÌÅÍ ÁÖµµ ºÐ¼®
US Public Health Spending on Biosimilars: A Data Driven Analysis
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1772631
¹ßÇàÀÏ
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Medical Affairs ÆòÆÇ(¹Ì±¹) - ±Ë¾ç¼º ´ëÀå¿°
Medical Affairs Reputations (US) - Ulcerative Colitis
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1769047
¹ßÇàÀÏ
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
MA(Medical Affairs) ÆòÆÇ(¹Ì±¹) - È³ó¼º ÇѼ±¿°
Medical Affairs Reputations (US) - Hidradenitis Suppurativa
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1764334
¹ßÇàÀÏ
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ºÐÀÚ»ý¹°Çпë È¿¼Ò, ½Ã¾à, ŰƮ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kit and Reagents, Enzymes), By Application (Cloning, NGS, PCR), By End Use, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772254
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
137 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¹Ì¼¼ÀÜÁ¸Áúȯ °Ë»ç ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ±â¼úº°, ¾Ï À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2033³â)
U.S. Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (Flow Cytometry, PCR, NGS), By Cancer Type (Hematological Malignancy, Solid Tumors), By End Use, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772235
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
100 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¾Èµå·Î°Õ¼ºÅ»¸ðÁõ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Ä¡·áº°, ÆÇ¸Åä³Îº°, ¼ºº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Sales Channel (Prescriptions, OTC), By Gender, By End Use, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772261
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
80 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ Å°Æ®·ç´Ù(Keytruda) ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ¿ëµµº°, ÁöºÒÀÚº°, À¯Åë ä³Îº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Keytruda Market Size, Share & Trends Analysis Report By Application, By Payer, By Distribution Channel, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772201
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
150 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ Rozanolixizumab(Rystiggo) ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : ÀûÀÀÁõº°, À¯Åë ä³Îº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Rozanolixizumab (Rystiggo) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis (gMG), Emerging Pipeline Applications), By Distribution Channel, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772246
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
150 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¹Ý·Áµ¿¹° Ä¡¾Æ °Ç° ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : À¯Çüº°, µ¿¹° À¯Çüº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, ºÎ¹® ¿¹Ãø(2025-2033³â)
U.S. Pet Dental Health Market Size, Share & Trends Analysis Report By Type (Products, Services), By Animal Type (Dogs, Cats), By Indication (Gum Disease, Dental Calculus, Oral Tumor), By Distribution Channel, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772217
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
150 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ AAV ¼öŹ °³¹ß ¹× Á¦Á¶ ±â°ü ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, ¿öÅ©Ç÷ο캰, ¹è¾ç À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. AAV Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Workflow, By Culture Type, By Application, By End Use, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771753
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
60 Pages
°¡°Ý
US $ 3,950 ->
£Ü 5,563,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¼¹æÇü ÄÚÆÃ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ±âÀ纰, ¿ëµµº°, Æú¸®¸Ó Àç·áº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Sustained Release Coatings Market Size, Share & Trends Analysis Report By Substrate, By Application, By Polymer Material, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1772481
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
80 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¹Ý·Áµ¿¹°¿ë ½ÉÀå ÀǾàǰ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ - ÀǾàǰº°, µ¿¹° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, À¯Åë ä³Îº°, ºÎ¹® ¿¹Ãø(2025-2033³â)
U.S. Companion Animal Cardiac Pharmaceuticals Market Size, Share & Trends Analysis Report By Pharmaceuticals, By Animals Type (Dogs, Cats, Horses), By Indication, By End Use, By Distribution Channel, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771715
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
150 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¿ø·áÀǾàǰ CDMO ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, Á¦Ç°º°, ÇÕ¼ºº°, ¾àÁ¦º°, ¿öÅ©Ç÷ο캰, ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771735
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
80 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ - Áø´Ü ±â¼úº°, À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), By Type, By End-use, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771712
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
80 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
MA(Medical Affairs) ÆòÆÇ(¹Ì±¹) - ´Ù¹ß¼º °æÈÁõ
Medical Affairs Reputations (US) - Multiple Sclerosis
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1749307
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
NPS+(¹Ì±¹) : °Ç¼±¼º °üÀý¿°
NPS+ (US) - Psoriatic Arthritis
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1749306
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ STI ¹× Áú¿° PCR °Ë»ç ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, º´Åº°, °Ë»ç À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. STI & Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections (STIs), Vaginal Infections), By Test Type, By End Use, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771648
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
100 Pages
°¡°Ý
US $ 4,950 ->
£Ü 6,972,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ¿ïÅä¹Ì¸®½º ÀǾàǰ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, À¯Åë ä³Îº°, ºÎ¹® ¿¹Ãø(2025-2033³â)
U.S. Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome ), By End Use, By Distribution Channel, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771583
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
150 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ °íºÐÀÚ Drug Discovery ¾Æ¿ô¼Ò½Ì ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ¿öÅ©Ç÷ο캰, ¼ºñ½ºº°, Ä¡·áÁ¦ ºÐ¾ßº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Large Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening), By Service, By Therapeutics Area (Ophthalmology, Hematology), By End-use, And Segment Forecasts, 2025 - 2033
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771594
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
120 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ °æÀ念¾ç Á¦Á¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : Á¦Ç°º°, Ç÷οì À¯Çüº°, ½ºÅ×ÀÌÁöº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, ÆÇ¸Å ä³Îº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage, By Indication, By End use, By Sales Channel, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771577
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
90 Pages
°¡°Ý
US $ 3,950 ->
£Ü 5,563,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ Áúºê¸®½ºÅ©(Zilbrysq) ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ÀûÀÀÁõº°, À¯Åë ä³Îº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Zilbrysq Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis ), By Distribution Channel, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771574
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
150 Pages
°¡°Ý
US $ 5,950 ->
£Ü 8,380,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹Ì±¹ÀÇ ´ëµ¿¸Æ Àå°ñ Æó»ö Áúȯ Ä¡·á ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(±â±âÀ¯Çüº°, óġº°, ÃÖÁ¾ ¿ëµµº°), ºÎ¹®º° ¿¹Ãø(2025-2030³â)
U.S. Aorto-iliac Occlusive Disease Treatment Market Size, Share & Trends Analysis Report By Device Type, By Procedure, By End-use, And Segment Forecasts, 2025 - 2030
¸®¼Ä¡»ç
Grand View Research, Inc.
»óǰÄÚµå
1771483
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
100 Pages
°¡°Ý
US $ 3,500 ->
£Ü 4,929,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
MA(Medical Affairs) ÆòÆÇ(¹Ì±¹) - ¼î±×·» ÁõÈıº
Medical Affairs Reputations (US) - Sjogren's Syndrome
¸®¼Ä¡»ç
FirstWord Group
»óǰÄÚµå
1770210
¹ßÇàÀÏ
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
AI ¹ø¿ª ¼ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 ->
£Ü 11,268,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
1
2
3
4
5
6
7
´ÙÀ½